{
    "organizations": [],
    "uuid": "3c47eef2c75cdd1ba2c0edd1c53278cdf7cbff2b",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-changsheng-bio-technology-sees-fy/brief-changsheng-bio-technology-sees-fy-2018-h1-net-profit-up-30-pct-to-60-pct-idUSL3N1S238P",
    "ord_in_thread": 0,
    "title": "BRIEF-Changsheng Bio-technology sees FY 2018 H1 net profit up 30 pct to 60 pct",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 25(Reuters) - Changsheng Bio-technology Co Ltd :\n* Sees FY 2018 H1 net profit to increase by 30 percent to 60 percent, or to be 343.5 million yuan to 422.8 million yuan\n* Says FY 2017 H1 net profit was 264.3 million yuan\n* The reason for the forecast is increased sales of vaccine products Source text in Chinese: goo.gl/Y7KUwN Further company coverage: (Beijing Headline News)\n ",
    "published": "2018-04-25T16:13:00.000+03:00",
    "crawled": "2018-04-26T20:42:31.023+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "changsheng",
        "co",
        "ltd",
        "see",
        "fy",
        "h1",
        "net",
        "profit",
        "increase",
        "percent",
        "percent",
        "million",
        "yuan",
        "million",
        "yuan",
        "say",
        "fy",
        "h1",
        "net",
        "profit",
        "million",
        "yuan",
        "reason",
        "forecast",
        "increased",
        "sale",
        "vaccine",
        "product",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}